Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 458 participants.
Also called NCT02702271
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 458 participants
- Sponsor
- Registry
-
NCT02702271
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02702271. Non-randomized; no masking; primary purpose prevention. Start 2018-05-07 (actual); primary completion 2020-01-28 (actual). Results posted on 2022-06-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
- Acronym
- PINNACLE FLX
- Condition
- Atrial Fibrillation
- Intervention (Device)
- WATCHMAN FLX
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02702271- Content hash
c917bd1c5c3f0dfeb11e7f7f5ba8424d1551e8df5f43dc42c4aa1a1e4733bec3